Gyre Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.44 | $-9.04 |
| FY2022 | $0.03 | $-9.03 |
| FY2023 | $-1.41 | $-7.33 |
| FY2024 | $0.05 | $-6.14 |
| FY2025 | $0.02 | $-2.83 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.44 | $-9.04 |
| FY2022 | $0.03 | $-9.03 |
| FY2023 | $-1.41 | $-7.33 |
| FY2024 | $0.05 | $-6.14 |
| FY2025 | $0.02 | $-2.83 |